Non ci sono recensioni
The World Health Organization Classification of Lymphoid Neoplasms
Pages 1-34
Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
The World Health Organization Classification of Lymphoid Neoplasms
Pages 1-34
Genomic Analysis of B-Cell Lymphomas
Pages 35-51
Molecular Profiling of Peripheral T-Cell Lymphomas
Pages 53-63
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
Pages 65-82
Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma
Pages 83-109
MALT Lymphoma (Extranodal Marginal Zone B-Cell Lymphoma)
Pages 111-126
Splenic Marginal Zone Lymphoma
Pages 127-136
Nodal Marginal Zone Lymphoma
Pages 137-142
Follicular Lymphoma
Pages 143-156
Mantle Cell Lymphoma
Pages 157-175
Diffuse Large B-Cell Lymphoma
Pages 177-202
Primary Mediastinal B-Cell Lymphoma
Pages 203-210
T-Cell Lymphomas
Pages 211-229
Burkitt Lymphoma
Pages 231-242
Lymphoblastic Lymphoma
Pages 243-256
AIDS-Related Lymphoma
Pages 257-266
Posttransplant Lymphomas
Pages 267-277
Cutaneous B-Cell Lymphoma
Pages 279-285
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
Pages 287-329
Central Nervous System Lymphoma
Pages 331-344
Monoclonal Antibodies for Lymphoma
Pages 345-361
Novel Agents Targeting Oncogenic Pathways in Lymphoma
Pages 363-370
Stem Cell Transplantation for Non-Hodgkin’s Lymphomas
Pages 371-402
Sei sicuro di voler eseguire questa azione?